EMShape® Neo Prime IV-W

The EMShape Neo Prime IV-W stands out by combining supra-maximal electromagnetic muscle stimulation with synchronized radio frequency (RF) heating in a single 30-minute session. While many EMS devices offer either muscle building OR fat reduction, the Neo Prime IV delivers up to 10–90 thousand intense muscle contractions while RF heating simultaneously penetrates dermal layers to stimulate collagen formation and improve skin elasticity. The ability to operate up to 4 handles simultaneously — treating multiple body areas or muscle groups at once — significantly improves treatment throughput for busy clinics. The desktop form factor also makes it more space-efficient than floor-standing alternatives while maintaining high power output.

The EMShape Neo Prime IV is designed to treat large muscle groups across the abdomen, buttocks, thighs, flanks, and arms. The desktop system supports up to 4 handles simultaneously, allowing clinics to treat multiple areas — such as both the abdomen and flanks — in a single 30-minute session. This makes it versatile for full-body sculpting protocols targeting the core, lower body, and upper arms.

The standard EMShape Neo Prime IV protocol calls for 4 to 6 sessions per treatment area, typically spaced 2 to 3 days apart over 2–4 weeks. Each session lasts approximately 30 minutes. Initial results may be visible after 2–3 sessions, with optimal outcomes appearing 2–4 weeks after completing the full course. Maintenance sessions (approximately 1 per month) are recommended to sustain muscle tone and fat reduction results. Individual protocols may vary based on the client's body composition goals.

The EMShape Neo Prime IV product listing does not specify a cleared FDA registration number or clearance status in its current data fields. While the device description references electromagnetic muscle stimulation technology similar to FDA-cleared HI-EMT devices, clinic buyers should independently verify the regulatory status with the manufacturer before purchasing, as regulatory claims vary by market and device version.